News
What Is a Fair Reimbursement Price for Orphan Drugs?
In the current draft of the Act on the Stabilisation of Finances for the Statutory Health Insurance in Germany, the threshold for orphan drugs shall decrease from currently €50 to €20m. A déjà vu? But wasn’t it €30m last time this was mentioned? Would €25m be a...
Revision of the EU Orphan Legislation – Implications for the German Benefit Assessment RAPS Euro Convergence on 10-12 May 2022 in Amsterdam, Netherlands
Back on stage! This year’s RAPS Euro Convergence in Amsterdam gave Dr. Meriem Bouslouk-Marx the floor to outline the interdependencies of EU and national legislative reviews. She analysed the implications of potential changes of the EU Orphan legislation such as...
Showing my stripes for this year’s Rare Disease Day
Oral and maxillofacial surgery was one major discipline during my last years of dental medicine at the Friedrich Schiller University in Jena. I was intrigued by the strange names of diseases and syndromes such as Hodgkin's, non-Hodgkin's and Behçet's. I remember very...
How can Germany pay for innovative therapies in the future? Fair access to medicines in the future – A challenge not only in times of corona. 11 March 2021, online event
With Advanced Therapy Medicinal Products (ATMPs), especially those for the treatment of rare diseases – innovative but also very expensive therapies – entering the market, a new challenge for payers has arisen. How can innovative medicinal products be financed in the...
A global fund to tackle antimicrobial resistance (AMR) New initiative takes on the antibiotic innovation challenge: Global launch event on 9 July 2020, online event
The International Federation of Pharmaceutical Manufacturers & Associations IFPMA, the European Federation of Pharmaceutical Industries and Associations EFPIA and the German Association of Research-Based Pharmaceutical Companies vfa organised an online event to launch...
How does Brazil deal with advanced therapies? Gene and advanced therapy – Creating value in the patient journey and in the health system on 23-24 October 2019 in Brasília, Brazil
Following the invitation of Sindusfarma (Syndicate of the Pharmaceutical Products Industry in the State of São Paulo) and Anvisa (Brazilian Health Regulatory Agency), stakeholders met to discuss Brazil’s challenges with advanced therapies. The two days with...
Ageing at home with geriatronics in Germany Presentation of Sami Haddadin “Robotics and artificial intelligence: People at the centre” at the annual meeting of the German Ethics Council “Care – Robot – Ethics. Ethical Challenges in the Technologisation of Care” on 26 June 2019 in Berlin, Germany
Professor Sami Haddadin, Director of the Munich School of Robotics and Machine Intelligence at the Technical University of Munich, started with a historical introduction to the subject. The Dartmouth summer research project on artificial intelligence (AI) in 1956 was...
Germany: Rare diseases at the Bundestag Extraordinary session HEALTH “The Rares” at the German Bundestag on 16 May 2019 in Berlin, Germany
Under the patronage of René Röspel, Social Democratic Party of Germany (SPD) parliamentary group, a multi-stakeholder session on rare diseases took place at the Bundestag. This platform offered the audience a discourse with representatives from policy, patients,...
Europe’s new leadership role in artificial intelligence Presentation of Thomas Metzinger "AI and Ethics: Europe First or Europe Alone?" at the Aspen Institute Germany’s 2nd Conference on Artificial Intelligence on 29 March 2019 in Berlin, Germany
Appointed by the European Commission to the High-Level Expert Group on Artificial Intelligence (AI), Thomas Metzinger, Professor of Theoretical Philosophy at the Johannes Gutenberg University Mainz, gave a small foretaste of what awaits European citizens with AI. As...
Is mandatory vaccination in Germany an option? Public meeting of the German Ethics Council: “National and international vaccination strategies” on 21 February 2019 in Berlin, Germany
German Ethics Council: National and international vaccination strategiesGermany received global attention after increasing rates of measles, one of the most contagious diseases effectively preventable by two doses of vaccine. As part of the current debate around...